Inscription à l’infolettre

Publications

Publications récentes

  • 22 octobre 2025

    Intracellular pH regulates ubiquitin-mediated degradation of the MAP kinase ERK3.

    Tesnière C, Boudghene-Stambouli F, Severin M, Poët M, Voisin L, Ponniah M, Pascariu M, Bonneil E, Trempe JF, Thibault P, Counillon L, Pedersen SF, Meloche S
    Proc Natl Acad Sci U S A 2025-10-22 ;122( 43 ):e2501825122

  • 8 octobre 2025

    A short SUMOylation tag modulates transcription factor activity.

    Bouchard AY, Vivet AJI, Cabana VC, Li C, Thibault P, Lussier MP, Mader S, Cappadocia L
    J Biol Chem 2025-10-08 ;110807

  • 25 septembre 2025

    MRAP2 modifies the signaling and oligomerization state of the melanocortin-4 receptor.

    Sohail I, Laurin SA, Kleinau G, Chunilal V, Morton A, Brenlla A, Kagiali ZCU, Blouin MJ, Tello JA, Beck-Sickinger AG, Lohse MJ, Scheerer P, Bouvier M, McCormick P, Annibale P, Biebermann H
    Nat Commun 2025-09-25 ;16( 1 ):8324

  • 18 septembre 2025

    mTOR inhibition reprograms cellular lipid homeostasis by inducing alternative lipid uptake and promoting cholesterol transport.

    Shin S, Han MJ, Patel I, Welsh AM, Sverdlov M, Cho W, Cologna SM, Roux PP, Yoon SO
    Mol Cell 2025-09-18 ;85( 18 ):3486-3504.e7

  • 18 septembre 2025

    Transgenic inducible MHC I overexpression in mouse alveolar type 2 cells.

    Mathé J, Brochu S, Saba-El-Leil MK, Coté C, Karia A, Harton S, Perreault C
    Transgenic Res 2025-09-18 ;34( 1 ):43

  • 8 septembre 2025

    The lncRNA ELDR suppresses tumorigenicity of AML by interfering with DNA replication and chromatin accessibility.

    Arman K, Ross J, Piskor EM, Lazzari L, Calderon V, Reulet G, Vera M, St Hilaire E, Wurtele H, Wilhelm B, Möröy T
    Blood Adv 2025-09-08 ;

  • 31 août 2025

    Nanofilament immunotherapy induces potent antitumor vaccine responses.

    Neil K, Génier S, Poisson ME, Douchin J, Giguère H, Daniel L, Gonzalez MF, Huang S, Trinh VQ, Tai LH, Rodrigue S, Millau JF
    J Immunother Cancer 2025-08-31 ;13( 8 ):

  • 27 août 2025

    ERK3/MAPK6 promotes triple-negative breast cancer progression through collective migration and EMT plasticity.

    Morazzo S, Fernandes S, Fortea M, Skálová H, Pereira-Sousa D, Cassani M, Vrzalová K, Kafka F, Vrbský J, Soulez M, Meloche S, Morten-Seternes O, Bosáková V, Shin J, Frič J, Haase K, Forte G
    Front Oncol 2025-08-27 ;15:1563969

Voir plus de publications